Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
China flag China · Delayed Price · Currency is CNY
23.98
-0.21 (-0.87%)
May 20, 2026, 11:30 AM CST

SHA:600196 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
13,06613,10413,52413,69416,24110,317
Trading Asset Securities
2,2262,2542,5961,888928.534,241
Cash & Short-Term Investments
15,29315,35816,12015,58217,17014,558
Cash Growth
-4.84%-4.73%3.45%-9.25%17.94%22.01%
Accounts Receivable
10,1039,9558,7658,4578,1726,474
Other Receivables
709.61712.79676.66636.27611.57875.26
Receivables
10,81210,6689,4429,0938,7837,538
Inventory
6,0326,2527,2597,5386,8825,473
Other Current Assets
1,8281,5431,6711,5802,4432,868
Total Current Assets
33,96533,82134,49133,79335,27930,437
Property, Plant & Equipment
24,29024,08423,41122,23916,02813,284
Long-Term Investments
28,20127,26925,86525,01225,54923,920
Goodwill
10,79710,81010,90510,85210,3379,400
Other Intangible Assets
14,09813,99914,46813,48212,47110,276
Long-Term Accounts Receivable
-213.33198.8383.0191.6677.4
Long-Term Deferred Tax Assets
990.95985.34757.78624.47442.57265.59
Long-Term Deferred Charges
9,1597,5936,2504,6754,0083,632
Other Long-Term Assets
1,4661,2801,1142,5122,8362,014
Total Assets
122,966120,054117,461113,470107,16493,306
Accounts Payable
4,9955,1445,9976,1606,2845,064
Accrued Expenses
1,8225,6495,4085,4145,5774,807
Short-Term Debt
16,35615,53018,71114,72811,93210,629
Current Portion of Long-Term Debt
7,6725,6353,9834,4225,2304,986
Current Portion of Leases
-348.4340.98329.53184.41141.5
Current Income Taxes Payable
550.91253.91278.7250.63619.34474.22
Current Unearned Revenue
1,1271,3001,2321,2001,5451,154
Other Current Liabilities
4,0592,5631,5011,2531,9282,063
Total Current Liabilities
36,58136,42437,45333,75833,29829,318
Long-Term Debt
12,57711,86210,44413,50512,1009,049
Long-Term Leases
2,9273,0512,5422,050744.99648.36
Long-Term Unearned Revenue
638.641,7421,093959.18986.85751.82
Long-Term Deferred Tax Liabilities
3,3273,2603,2453,4453,3633,130
Other Long-Term Liabilities
3,2471,8742,7513,1372,5622,029
Total Liabilities
59,29758,21457,52756,85353,05544,927
Common Stock
2,6702,6702,6712,6722,6722,563
Additional Paid-In Capital
-16,37716,59116,85316,99214,041
Retained Earnings
32,94232,07129,54527,50126,17023,858
Treasury Stock
-607.96-607.96-234.38-41.93-53.25-
Comprehensive Income & Other
14,142-1,769-1,313-1,300-1,198-1,266
Total Common Equity
49,14748,74247,26145,68544,58239,196
Minority Interest
14,52313,09912,67310,9319,5269,184
Shareholders' Equity
63,66961,84059,93456,61654,10948,380
Total Liabilities & Equity
122,966120,054117,461113,470107,16493,306
Total Debt
39,53236,42736,02135,03530,19125,454
Net Cash (Debt)
-24,239-21,069-19,901-19,453-13,021-10,896
Net Cash Per Share
-9.16-7.96-7.45-7.29-4.99-4.25
Filing Date Shares Outstanding
2,6402,6402,6572,6722,6722,563
Total Common Shares Outstanding
2,6402,6402,6582,6722,6722,563
Working Capital
-2,616-2,604-2,96234.991,9811,118
Book Value Per Share
18.6218.4717.7817.1016.6815.29
Tangible Book Value
24,25223,93321,88821,35121,77419,519
Tangible Book Value Per Share
9.199.078.237.998.157.62
Land
-1,021943.68951.74201.31203.68
Buildings
-14,06112,92711,4717,7336,605
Machinery
-16,34715,39214,02610,7009,197
Construction In Progress
-3,0553,4354,9384,8973,618
Source: S&P Global Market Intelligence. Standard template. Financial Sources.